Latest News

Johnson & Johnson once offered woman $1.3M to drop talcum powder lawsuit

August 19th, 2016

Medical giant Johnson & Johnson once offered a woman $1.3 million to drop a talcum powder lawsuit alleging that the company’s product caused cancer. Diane Berg filed the first baby powder lawsuit in 2009 after using the product for most of her life and developing ovarian cancer at age 49. More »

Study finds potential link between PPIs and dementia

August 18th, 2016

A new study has found a potential link between the use of proton pump inhibitors (PPIs) and developing new dementia. The study followed more than 73,000 elderly patients who had no signs of dementia for 7 years, cataloguing any developments. More »

FDA issues updated fluoroquinolone warning labels

August 11th, 2016

The U.S. Food and Drug Administration announced an update to fluoroquinolone warning labels, enhancing their warning about risks of serious FLQ side effects. The FDA also aims to reduce the use of the powerful antibiotics to only patients with certain serious infections. More »

Sanofi issues Taxotere recall over fears of drug being too concentrated

July 26th, 2016

Sanofi Aventis issued a Taxotere recall for fifteen batches of its chemotherapy drug after an error in the manufacturing process could have led the vials to be too concentrated. Taxotere is already a much more powerful drug than alternative chemotherapy treatment drugs. More »

Proton pump inhibitor use linked to low magnesium in dialysis patients

July 25th, 2016

Proton pump inhibitors are more likely to cause low serum magnesium levels in hemodialysis patients, according to a new study reported in Hemodialysis International. Low magnesium levels in the presence of inflammation can in turn lead to an increased 1-year mortality rate, researchers found. More »

FLQ’s land on Washington Post’s list of common medications with scary side effects

July 22nd, 2016

Powerful and common antibiotics known as fluoroquinolones (FLQs) landed on the Washington Post’s list of common medications with “scary side effects.” FLQs such as Levaquin, Avelox and Cipro are among the most common antibiotics prescribed by doctors, but could lead to an increased risk of severe side effects. More »

Michigan woman details battle with Levaquin side effects

June 15th, 2016

A Michigan woman who developed severe Levaquin side effects after being given the powerful antibiotic detailed her battle to a local Fox news station. Stacey Halason told the station that she has been in pain “every day since taking the drug in 2009” and that she “wanted to die.” More »

TrapEase IVC filter found to have higher rate of complications

June 13th, 2016

The TrapEase inferior vena cava filter (IVC filter) has been found to have a higher rate of symptomatic thrombosis than alternative IVC filters. Manufacturer by Johnson & Johnson, the TrapEase IVC filter has been on the market since 2000 and has undergone significantly fewer studies than alternative IVC filters. More »

Johnson & Johnson knew of TrapEase filter complications as early as 2011

June 13th, 2016

Medical device maker Johnson & Johnson knew about complications associated with the TrapEase inferior vena cava (IVC) filter as early as 2011. A Japanese study conducted at the time found that the TrapEase IVC filters had an abnormally high rate of fracture in patients who received them to prevent blood clots when anti-clotting medications prove ineffective. More »

PPIs may lead to kidney problems by prematurely aging blood vessels

May 18th, 2016

Recent research from the Houston Methodist Research Institute has discovered one way that proton pump inhibitors (PPIs) may lead to an increased risk of severe side effects, including kidney problems. Doctor John P. Cooke led a research team that discovered PPIs, which include common over-the-counter acid reflux drugs Nexium and Prevacid, prematurely age the endothelial cells that line the interior of blood vessels. More »

Page 1 of 6112345...102030...Last »
I am currently represented by an attorney
*Required fields